Evidence map›Paper›PMID 39303842›Full record

ArticleExperimental eye research2024

Comparative analysis of In vivo endothelial cell translatomes across central nervous system vascular beds.

Ana J Chucair-Elliott, Kevin Pham, Audrey C A Cleuren, Christopher M Schafer, Courtney T Griffin, Sarah R Ocanas, Willard M Freeman, Michael H Elliott

Abstract readComparative Study
In one paragraph

Article in Experimental eye research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ana J Chucair-ElliottGenes & Human Disease Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA. Electronic address: ana-chucair@omrf.org.
Kevin PhamGenes & Human Disease Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
Audrey C A CleurenCardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
Christopher M SchaferCardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
Courtney T GriffinCardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
Sarah R OcanasGenes & Human Disease Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA; Department of Biochemistry & Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Willard M FreemanGenes & Human Disease Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA. Electronic address: bill-freeman@omrf.org.
Michael H ElliottDepartment of Ophthalmology, McGee Eye Institute, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA; Department of Biochemistry & Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. Electronic address: michael-elliott@ouhsc.edu.

Funding

Viral sensor IFIH1 promotes SLE through an altered interferon programP20GM139763 · NIGMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI Jon Iker Etchegaray · 2021 to 2026
$20.3M
Targeted DNA Methylation and Mitochondrial Heteroplasmy CoreP30AG050911 · NIA · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Matthew John Hart · 2015 to 2026
$13.9M
P30-CENTER CORE GRANT FOR VISION RESEARCHP30EY021725 · NEI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Michelle C Callegan, MICHAEL H ELLIOTT · 2011 to 2026
$10.5M
Protease-Mediated Vascular Instability in Development and DiseaseR35HL144605 · NHLBI · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI GRIFFIN, COURTNEY T · 2019 to 2025
$5.9M
Role of Caveolin-1 in the Maintenance of Blood-retinal Barrier IntegrityR01EY019494 · NEI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI ELLIOTT, MICHAEL H · 2010 to 2025
$4.9M
Sex divergence and cell specificity of age-related hippocampal DNA modificationsR01AG059430 · NIA · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI FREEMAN, WILLARD M · 2019 to 2023
$2.7M
Retinal Pigmented Epithelium Epigenome Dysregulation With Aging and Modulation by DietR01EY034946 · NEI · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI Ana Julia Chucair-Elliott, WILLARD M FREEMAN · 2024 to 2026
$1.6M
Dynamics of the brain epigenome with agingI01BX003906 · VA · OKLAHOMA CITY VA MEDICAL CENTER · PI FREEMAN, WILLARD M · 2018 to 2021
–
BLRD VA I01 BX003906BLRD VA IK6 BX006033NEI NIH HHS P30 EY021725NEI NIH HHS R01 EY019494NEI NIH HHS R01 EY034946NHLBI NIH HHS R35 HL144605NIA NIH HHS P30 AG050911NIA NIH HHS R01 AG059430NIGMS NIH HHS P20 GM139763
6 · The paper itself

Abstract

Endothelial cells (ECs) display organ- and tissue-specific heterogeneity. In the eye, the retinal and choroidal vascular beds are distinct networks with different molecular and morphological properties that serve location-specific functions, i.e., the former maintaining a tight barrier and the latter, a permeable fenestrated vasculature. Given that retinal health critically relies on the function of these vascular beds and that their dysfunction is implicated in a variety of retinal diseases, a molecular understanding of both physiological and pathophysiological characteristics of these distinct vasculatures is critical. Given their interspersed anatomic distribution among parenchymal cells, the study of EC gene expression, in vivo, has been hampered by the challenge of isolating pure populations of ocular ECs in sufficient quantities for large-scale transcriptomics. To address this challenge, we present a methodological and analytical workflow to facilitate inter-tissue comparisons of the in vivo EC translatome isolated from choroid, retina, and brain using the Cre-inducible NuTRAP flox construct and two widely-used endothelial Cre mouse lines: constitutive Tie2-Cre and tamoxifen-inducible Cdh5-CreERT2. For each Cre line, inter-tissue comparison of TRAP-RNAseq enrichment (TRAP-isolated translatome vs input transcriptome) showed tissue-specific gene enrichments with differential pathway representation. For each mouse model, inter-tissue comparison of the EC translatome (choroid vs brain, choroid vs retina, and brain vs retina) showed over 50% overlap of differentially expressed genes (DEGs) between the three paired comparisons, with differential pathway representation for each tissue. Pathway analysis of DEGs in the Cdh5-NuTRAP vs Tie2-NuTRAP comparison for retina, choroid, and brain predicted inhibition of processes related to myeloid cell function and activation, consistent with more specific targeting of ECs in the Cdh5-NuTRAP than in the Tie2-NuTRAP model which also targets hematopoietic progenitors giving rise to immune cells. Indeed, while TRAP enriches for EC transcripts in both models, myeloid transcripts were also captured in the Tie2-NuTRAP model which was confirmed using cell sorting. We suggest experimental/analytical considerations should be taken when selecting Cre-lines to target ECs.

Indexed as

ChoroidEndothelial CellsRetinal VesselsAnimalsBrainEndothelium, VascularMiceMice, Inbred C57BLRetinaTranscriptomeBrainChoroidRetinaTranslating ribosome affinity purification (TRAP)TranslatomicsVascular endothelium

Identifiers

PMID39303842
PMCPMC11532013

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.